内皮活化应激指数预测糖尿病患者的全因死亡率和心血管死亡率:一项全国性研究。

IF 3 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Gaiying Dong, Tingting Wu, Xiaofan Gu, Yuyi Feng, Liangliang Wu, Zhiwen Hu
{"title":"内皮活化应激指数预测糖尿病患者的全因死亡率和心血管死亡率:一项全国性研究。","authors":"Gaiying Dong,&nbsp;Tingting Wu,&nbsp;Xiaofan Gu,&nbsp;Yuyi Feng,&nbsp;Liangliang Wu,&nbsp;Zhiwen Hu","doi":"10.1111/jdi.70130","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Evidence suggests that the Endothelial Activation and Stress Index (EASIX) predicts mortality in endothelium-related conditions, but its link to mortality risk in diabetes remains unclear. This study investigates the association between EASIX and mortality risk in diabetes patients.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We included 3,252 diabetes patients from seven National Health and Nutrition Examination Survey cycles (2003–2016). Mortality data were sourced from National Death Index records. Restricted cubic spline (RCS) regression assessed the EASIX-mortality risk relationship, while the maximally selected rank statistics method (MSRSM) identified the optimal EASIX cutoff for survival outcomes. Weighted multivariable Cox regression models evaluated the association of EASIX with all-cause and cardiovascular mortality.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Over a median follow-up of 91 months, 895 (27.5%) of 3,252 diabetes patients died, including 260 (8.0%) from cardiovascular and 635 (19.5%) from noncardiovascular causes. RCS analysis showed a positive association between EASIX and both all-cause and cardiovascular mortality. Each one-unit EASIX increase raised all-cause and cardiovascular mortality risks by 27% and 24%, respectively. MSRSM classified patients into higher (&gt;0.70) and lower (≤0.70) EASIX groups. Those with higher EASIX had a significantly greater risk of all-cause (HR 1.56, 95% CI 1.21–2.01) and cardiovascular mortality (HR 2.05, 95% CI 1.33–3.16). Time-dependent receiver operating characteristic analysis showed AUCs for 1-, 3-, 5-, and 10-year survival were 0.78, 0.72, 0.70, and 0.69 (all-cause) and 0.90, 0.81, 0.76, and 0.73 (cardiovascular).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Elevated EASIX is independently associated with increased all-cause and cardiovascular mortality in diabetes patients, highlighting its potential as a valuable clinical biomarker.</p>\n </section>\n </div>","PeriodicalId":51250,"journal":{"name":"Journal of Diabetes Investigation","volume":"16 10","pages":"1870-1880"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.70130","citationCount":"0","resultStr":"{\"title\":\"Endothelial Activation Stress Index predicts all-cause and cardiovascular mortality in patients with diabetes: A nationwide study\",\"authors\":\"Gaiying Dong,&nbsp;Tingting Wu,&nbsp;Xiaofan Gu,&nbsp;Yuyi Feng,&nbsp;Liangliang Wu,&nbsp;Zhiwen Hu\",\"doi\":\"10.1111/jdi.70130\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>Evidence suggests that the Endothelial Activation and Stress Index (EASIX) predicts mortality in endothelium-related conditions, but its link to mortality risk in diabetes remains unclear. This study investigates the association between EASIX and mortality risk in diabetes patients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We included 3,252 diabetes patients from seven National Health and Nutrition Examination Survey cycles (2003–2016). Mortality data were sourced from National Death Index records. Restricted cubic spline (RCS) regression assessed the EASIX-mortality risk relationship, while the maximally selected rank statistics method (MSRSM) identified the optimal EASIX cutoff for survival outcomes. Weighted multivariable Cox regression models evaluated the association of EASIX with all-cause and cardiovascular mortality.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Over a median follow-up of 91 months, 895 (27.5%) of 3,252 diabetes patients died, including 260 (8.0%) from cardiovascular and 635 (19.5%) from noncardiovascular causes. RCS analysis showed a positive association between EASIX and both all-cause and cardiovascular mortality. Each one-unit EASIX increase raised all-cause and cardiovascular mortality risks by 27% and 24%, respectively. MSRSM classified patients into higher (&gt;0.70) and lower (≤0.70) EASIX groups. Those with higher EASIX had a significantly greater risk of all-cause (HR 1.56, 95% CI 1.21–2.01) and cardiovascular mortality (HR 2.05, 95% CI 1.33–3.16). Time-dependent receiver operating characteristic analysis showed AUCs for 1-, 3-, 5-, and 10-year survival were 0.78, 0.72, 0.70, and 0.69 (all-cause) and 0.90, 0.81, 0.76, and 0.73 (cardiovascular).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Elevated EASIX is independently associated with increased all-cause and cardiovascular mortality in diabetes patients, highlighting its potential as a valuable clinical biomarker.</p>\\n </section>\\n </div>\",\"PeriodicalId\":51250,\"journal\":{\"name\":\"Journal of Diabetes Investigation\",\"volume\":\"16 10\",\"pages\":\"1870-1880\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.70130\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Diabetes Investigation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jdi.70130\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Investigation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jdi.70130","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

有证据表明,内皮激活和应激指数(EASIX)可以预测内皮相关疾病的死亡率,但其与糖尿病死亡风险的关系尚不清楚。本研究探讨EASIX与糖尿病患者死亡风险的关系。方法:纳入2003-2016年7个国家健康与营养调查周期的3252例糖尿病患者。死亡率数据来源于国家死亡指数记录。限制性三次样条(RCS)回归评估了EASIX与死亡风险的关系,而最大选择秩统计方法(MSRSM)确定了EASIX生存结局的最佳截止点。加权多变量Cox回归模型评估EASIX与全因死亡率和心血管死亡率的关系。结果:在91个月的中位随访中,3252例糖尿病患者中有895例(27.5%)死亡,其中260例(8.0%)死于心血管原因,635例(19.5%)死于非心血管原因。RCS分析显示EASIX与全因死亡率和心血管死亡率呈正相关。EASIX每增加一个单位,全因和心血管死亡风险分别增加27%和24%。MSRSM将患者分为EASIX高(≤0.70)组和EASIX低(≤0.70)组。EASIX较高的患者的全因风险(HR 1.56, 95% CI 1.21-2.01)和心血管死亡率(HR 2.05, 95% CI 1.33-3.16)显著增加。时间依赖性受试者工作特征分析显示,1年、3年、5年和10年生存率的auc分别为0.78、0.72、0.70和0.69(全因),0.90、0.81、0.76和0.73(心血管)。结论:EASIX升高与糖尿病患者全因死亡率和心血管死亡率增加独立相关,突出了其作为有价值的临床生物标志物的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Endothelial Activation Stress Index predicts all-cause and cardiovascular mortality in patients with diabetes: A nationwide study

Endothelial Activation Stress Index predicts all-cause and cardiovascular mortality in patients with diabetes: A nationwide study

Introduction

Evidence suggests that the Endothelial Activation and Stress Index (EASIX) predicts mortality in endothelium-related conditions, but its link to mortality risk in diabetes remains unclear. This study investigates the association between EASIX and mortality risk in diabetes patients.

Methods

We included 3,252 diabetes patients from seven National Health and Nutrition Examination Survey cycles (2003–2016). Mortality data were sourced from National Death Index records. Restricted cubic spline (RCS) regression assessed the EASIX-mortality risk relationship, while the maximally selected rank statistics method (MSRSM) identified the optimal EASIX cutoff for survival outcomes. Weighted multivariable Cox regression models evaluated the association of EASIX with all-cause and cardiovascular mortality.

Results

Over a median follow-up of 91 months, 895 (27.5%) of 3,252 diabetes patients died, including 260 (8.0%) from cardiovascular and 635 (19.5%) from noncardiovascular causes. RCS analysis showed a positive association between EASIX and both all-cause and cardiovascular mortality. Each one-unit EASIX increase raised all-cause and cardiovascular mortality risks by 27% and 24%, respectively. MSRSM classified patients into higher (>0.70) and lower (≤0.70) EASIX groups. Those with higher EASIX had a significantly greater risk of all-cause (HR 1.56, 95% CI 1.21–2.01) and cardiovascular mortality (HR 2.05, 95% CI 1.33–3.16). Time-dependent receiver operating characteristic analysis showed AUCs for 1-, 3-, 5-, and 10-year survival were 0.78, 0.72, 0.70, and 0.69 (all-cause) and 0.90, 0.81, 0.76, and 0.73 (cardiovascular).

Conclusions

Elevated EASIX is independently associated with increased all-cause and cardiovascular mortality in diabetes patients, highlighting its potential as a valuable clinical biomarker.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Diabetes Investigation
Journal of Diabetes Investigation ENDOCRINOLOGY & METABOLISM-
CiteScore
6.50
自引率
9.40%
发文量
218
审稿时长
6-12 weeks
期刊介绍: Journal of Diabetes Investigation is your core diabetes journal from Asia; the official journal of the Asian Association for the Study of Diabetes (AASD). The journal publishes original research, country reports, commentaries, reviews, mini-reviews, case reports, letters, as well as editorials and news. Embracing clinical and experimental research in diabetes and related areas, the Journal of Diabetes Investigation includes aspects of prevention, treatment, as well as molecular aspects and pathophysiology. Translational research focused on the exchange of ideas between clinicians and researchers is also welcome. Journal of Diabetes Investigation is indexed by Science Citation Index Expanded (SCIE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信